Ameritas Investment Partners’s Precision BioSciences DTIL Stock Holding History

Ameritas Investment Partners’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-134	Closed	-$12K	–	3112
2022 Q1	$12K	Hold	134	–	–	﹤0.01%	2734
2021 Q4	$30K	Hold	134	–	–	﹤0.01%	2432
2021 Q3	$47K	Hold	134	–	–	﹤0.01%	2195
2021 Q2	$51K	Hold	134	–	–	﹤0.01%	2165
2021 Q1	$42K	Hold	134	–	–	﹤0.01%	2184
2020 Q4	$34K	Hold	134	–	–	﹤0.01%	2203
2020 Q3	$25K	Hold	134	–	–	﹤0.01%	2258
2020 Q2	$34K	Buy	134 +31	+30%	+$6.79K	﹤0.01%	2058
2020 Q1	$19K	Hold	103	–	–	﹤0.01%	2208
2019 Q4	$43K	Buy	103 +76	+281%	+$23.9K	﹤0.01%	2012
2019 Q3	$7K	Hold	27	–	–	﹤0.01%	2842
2019 Q2	$11K	Buy	+27	New	+$10.9K	﹤0.01%	2759

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameritas Investment Partners's DTIL Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 134 shares — an estimated $12K sold.

Ameritas Investment Partners first reported a position in DTIL in Q2 2019 and held it in 12 quarters. The position peaked at $51K in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Ameritas Investment Partners reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 134 Precision BioSciences shares in Q2 2022, an estimated $12K.
Ameritas Investment Partners first reported a position in Precision BioSciences in Q2 2019 and held it in 12 quarters.
Ameritas Investment Partners's Precision BioSciences position peaked at $51K in Q2 2021.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.